...
Can You Use Dermoscopy to Detect Breslow Thickness in Acral Melanomas?
November 8, 2018

Acral melanomas (AM) are often misdiagnosed or there is a delay to appropriate diagnosis, leading to a possible delay in treatment and a corresponding poorer prognosis. Dermoscopy can be helpful for early detection by differentiating AM from benign acral melanocytic nevi. While depth of invasion is the most critical prognostic factor, a recent study hypothesized

...
SDPA Fall 2018 | Biopsy Techniques: Getting the Most Out of Your Specimens
November 3, 2018

On the 3rd day of the 16th Annual Fall Dermatology Conference, Dr. Daniel Miller from the University of Minnesota Medical Center, presented a clinically relevant lecture on Biopsy Techniques: Getting the Most Out of Your Specimens. He started his lecture by highlighting that more than 2.2 million cutaneous biopsies are performed annually and that the

...
SDPA Fall 2018 | Product Theater | Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis

At the first product theater on day 3 of the 16th Annual Fall Dermatology Conference, Dr. Firas Hougeir shared his extensive knowledge and experience in the treatment of patients with psoriasis with his lecture entitled Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis. Dr. Hougeir started his lecture

...
SDPA Fall 2018 | Walking Tour of the 2018 Abstracts

The sun in Orlando is bright and the weather is clear and cooler on the third full day of SDPA’s 16th Annual Fall Dermatology Conference. This morning Dr. Mark Russell led a Walking Tour of the 2018 Abstracts. He walked with a group of SDPA members as they viewed the posters presented in the Tuscan

...
SDPA Fall 2018 | Dupixent (dupilumab)

On day two of the 16th Annual Fall Conference, Cynthia Trickett, MPAS, PA-C, DFAAPA shared her clinical insights regarding the treatment of atopic dermatitis (AD) in her lecture on Dupixent. AD is estimated to affect 3.2% of adults in the US and around 1.6 million with moderate to severe AD remain uncontrolled despite treatment. Ms.

...
SDPA Fall 2018 | What’s New in Biologics

On Friday November 2, the second full day of SDPA’s 16th Annual Fall Dermatology Conference Dr. Misha Rosenbach spoke about What’s New in Biologics. Many of the topics he discussed included off label use since indications are still limited. His specialty is granulomatous and neutrophilic diseases and he has used biologic therapy for such conditions